Advanced in Neonatal Onset Multisystem Inflammatory Disease

Yuichi Yamasaki

Kagoshima, JP 
Advanced in Neonatal Onset Multisystem Inflammatory Disease
Kagoshima, JP 
OverviewLocationsClinical Research

Overview

Yuichi Yamasaki practices in Kagoshima, Japan. Yamasaki is rated as an Advanced expert by MediFind in the treatment of Neonatal Onset Multisystem Inflammatory Disease. Their top areas of expertise are Blau Syndrome, Juvenile Idiopathic Arthritis (JIA), Familial Cold Autoinflammatory Syndrome, and Neonatal Onset Multisystem Inflammatory Disease.

Their clinical research consists of co-authoring 19 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Neonatal Onset Multisystem Inflammatory Disease.

Locations

Kagoshima, Japan
Other Locations
Ube, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
A Multi-Center, Open-Label Trial to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Subcutaneously Administered Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Combination product
Study Drug: Belimumab
Study Phase: Phase 2

19 Total Publications

Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus.
Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus.
Journal: Modern rheumatology
Published: July 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamasaki's expertise for a condition
ConditionClose
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile